Skip to main content
SpringerLink
Log in

Diagnostik Therapie bei gestörter Ovarfunktion

  • Chapter
  • First Online:
Klinische Endokrinologie für Frauenärzte

  • 168 Accesses

Zusammenfassung

Die Beurteilung der Ovarfunktion ist eine der häufigsten Fragestellungen in der frauenärztlichen Praxis, speziell in der Sterilitätssprechstunde. Sie ist von der jeweiligen Lebensphase abhängig und bedeutet nicht grundsätzlich ovulatorisch.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Literatur

  • Adashi EY (1984) Clomiphene citrate: mechanism(s) and site(s) of action – a hypothesis revisited. Fertil Steril 42:331

    Article  CAS  PubMed  Google Scholar 

  • Aeyers JWT, Peterson EP, Knight L, Grady E (1989) Clomiphene and poor cervical mucus – ovulatory dysfunction, not “antioestrogen”. In: 45th annual meeting, American Fertility Society, Abstract. Brmingham, Alabama

    Google Scholar 

  • Alexander EK, Pearce EN, Brent GA et al (2017) Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and the postpartum. Thyroid 27:315–389

    Article  PubMed  Google Scholar 

  • Alliende ME, Cabezon C, Figueroa H, Kottmann C (2005) Cervicovaginal fluid changes to detect ovulation accurately. Am J Obstet Gynecol 193:71

    Article  PubMed  Google Scholar 

  • Althuis MD, Moghissi KS, Westhoff CL et al (2005) Uterine cancer after use of clomiphene citrate to induce ovulation. Am J Epidemiol 161:607

    Article  PubMed  Google Scholar 

  • Antaki R, Dean NL, Lapensee L, Racicot MH, Menard S, Kadoch IJ (2011) An algorithm combining ultrasound monitoring and urinary luteinizing hormone testing: a novel approach for intrauterine insemination timing. J Obstet Gynaecol Can 33:1248

    Article  PubMed  Google Scholar 

  • Apter D, Vihko R (1983) Early menarche, a risk factor for breast cancer, indicates early onset of ovulatory cycles. J Clin Endocrinol Metab 57:82

    Article  CAS  PubMed  Google Scholar 

  • ASRM Practice Committee (2015) Current clinical irrelevance of luteal phase deficiency: a committee opinion. Fertil Steril 103(4):e27–e32

    Article  Google Scholar 

  • Azziz R, Black VY, Knochenhauer ES et al (1999) Ovulation after glucocorticoid suppression of adrenal androgens in the polycystic ovary syndrome is not predicted by the basal dehydroepiandrosterone sulfate level. J Clin Endocrinol Metab 84:946

    CAS  PubMed  Google Scholar 

  • Beebeejaun Y, Athithan A, Copeland TP, Kamath MS, Sarris I, Sunkara SK (2021) Risk of breast cancer in women treated with ovarian stimulation drugs for infertility: a systematic review and meta-analysis. Fertil Steril 116(1):198–207

    Article  CAS  PubMed  Google Scholar 

  • Bentley PJ (1980) Endocrine pharmacology. Cambridge University Press, Cambridge, S 197

    Google Scholar 

  • Bilian X, Heng Z, Shang-Chun W et al (2010) Conception probabilities at different days of menstrual cycle in Chinese women. Fertil Steril 94:1208

    Article  PubMed  Google Scholar 

  • Boehm U, Bouloux PM, Dattani MT, de Roux N, Dodé C, Dunkel L, Dwyer AA, Giacobini P, Hardelin JP, Juul A, Maghnie M, Pitteloud N, Prevot V, Raivio T, Tena-Sempere M, Quinton R, Young J (2015) Expert consensus document: European consensus statement on congenital hypogonadotropic hypogonadism--pathogenesis, diagnosis and treatment. Nat Rev Endocrinol 11(9):547–564

    Article  PubMed  Google Scholar 

  • Bordewijk EM, Ng KYB, Rakic L, Mol BWJ, Brown J, Crawford TJ, van Wely M (2020) Laparoscopic ovarian drilling for ovulation induction in women with anovulatory polycystic ovary syndrome. Cochrane Database Syst Rev 2(2):CD001122

    PubMed  Google Scholar 

  • Braat DDM, Schoemaker R, Schoemaker J (1991) Life table analysis of fecundity in intravenously gonadotropin-releasing hormone-treated patients with normogonadotropic and hypogonadotropic amenorrhea. Fertil Steril 55:266

    Article  CAS  PubMed  Google Scholar 

  • Brown J, Farquhar C (2016) Clomiphene and other antioestrogens for ovulation induction in polycystic ovarian syndrome. Cochrane Database Syst Rev 12:CD002249

    PubMed  Google Scholar 

  • Choi SH, Shapiro H, Robinson GE et al (2005) Psychologiclal side-effects of clomiphene citrate and human menopausal gonadotrophin. J Psychosom Obstet Gynaecol 26:93

    Article  CAS  PubMed  Google Scholar 

  • Coetsier T, Dhont M (1996) Complete and partial luteinized unruptured follicle syndrome after ovarian stimulation with clomiphene citrate/human menopausal gonadotrophin/human chorionic gonadotrophin. Hum Reprod 11:583

    Article  CAS  PubMed  Google Scholar 

  • Colao A, Abs R, Barcena DG, Chanson P, Paulus W, Kleinberg DL (2008) Pregnancy outcomes following cabergoline treatment: extended results from a 12-year observational study. Clin Endocrinol 68:66

    Article  CAS  Google Scholar 

  • Coughlan C, Fitzgerald J, Milne P, Wingfield M (2010) Is it safe to prescribe clomiphene citrate without ultrasound monitoring facilities? J Obstet Gynaecol 30:393

    Article  CAS  PubMed  Google Scholar 

  • Dasharathy SS, Mumford SL, Pollack AZ et al (2012) Menstrual bleeding patterns among regularly menstruating women. Am J Epidemiol 175:536

    Article  PubMed  PubMed Central  Google Scholar 

  • Davies J, Kadir RA (2012) Endometrial haemostasis and menstruation. Rev Endocr Metab Disord 13:289

    Article  CAS  PubMed  Google Scholar 

  • De Cecco L, Venturini PL, Ragni N et al (1982) Dopaminergic ergots in lactation and cycle disturbance. In: Calne DB, Horowski R, McDonald RJ, Wuttke W (Hrsg) Lisuride and other dopamin agonists. Raven, New York, S 291

    Google Scholar 

  • DeUgarte CM, Bartolucci AA, Azziz R (2005) Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment. Fertil Steril 83(5):1454–1460

    Article  CAS  PubMed  Google Scholar 

  • Deutsches IVF-Register DIR (2020) Jahrbuch 2019. J Reproduktionsmed Endokrinol 17:199–239

    Google Scholar 

  • Devroey P, Mannaerts B, Smitz J et al (1993) First established pregnancy and birth after ovarian stimulation with recombinant human follicle stimulating hormone (Org 32489). Hum Reprod 8:863

    Article  CAS  PubMed  Google Scholar 

  • Dunson DB, Baird DD, Wilcox AJ, Weinberg CR (1999) Day-specific probabilities of clinical pregnancy based on two studies with imperfect measures of ovulation. Hum Reprod 14:1835

    Article  CAS  PubMed  Google Scholar 

  • Ecochard R, Boehringer H, Rabilloud M, Marret H (2001) Chronological aspects of ultrasonic, hormonal, and other indirect indices of ovulation. BJOG 108:822

    CAS  PubMed  Google Scholar 

  • Eftekhari N, Mohammadalizadeh S (2009) Pregnancy rate following bromocriptine treatment in infertile women with galactorrhea. Gynecol Endocrinol 25(2):122–124

    Article  CAS  PubMed  Google Scholar 

  • Ehrmann DA, Barnes RB, Rosenfield RL, Cavaghan MK, Imperial J (1999) Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care 22:141

    Article  CAS  PubMed  Google Scholar 

  • Eisenhardt S, Schwarzmann N, Henschel V et al (2006) Early effects of metformin in women with polycystic ovary syndrome: a prospective, randomized, double-blind, placebo-controlled trial. J Clin Endocrinol Metab 91:946

    Article  CAS  PubMed  Google Scholar 

  • Epperson CN, Steiner M, Hartlage SA, Eriksson E, Schmidt PJ, Jones I, Yonkers KA (2012) Premenstrual dysphoric disorder: evidence for a new category for DSM-5. Am J Psychiatry 169(5):465

    Article  PubMed  PubMed Central  Google Scholar 

  • ESHRE Capri Workshop Group (2012) Health and fertility in World Health Organization group 2 anovulatory women. Hum Reprod Update 18:586

    Article  Google Scholar 

  • Farhi J, Soule S, Jacobs HS (1995) Effect of laparoscopic ovarian electrocautery on ovarian response and outcome of treatment with gonadotropins in clomiphene citrate-resistant patients with polycystic ovary syndrome. Fertil Steril 64:930

    Article  CAS  PubMed  Google Scholar 

  • Farhi J, Orvieto R, Gavish O, Homburg R (2010) The association between follicular size on human chorionic gonadotropin day and pregnancy rate in clomiphene citrate treated polycystic ovary syndrome patients. Gynecol Endocrinol 26:546

    Article  CAS  PubMed  Google Scholar 

  • Farquhar C, Brown J, Marjoribanks J (2012) Laparoscopic drilling by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome. Cochrane Database Syst Rev 6:CD001122

    Google Scholar 

  • Feig DS, Donovan LE, Zinman B, Sanchez JJ, Asztalos E, Ryan EA, Fantus IG, Hutton E, Armson AB, Lipscombe LL, Simmons D, JFR B, Karanicolas PJ, Tobin S, HD MI, Tian SY, Tomlinson G, Murphy KE, MiTy Collaborative Group (2020) Metformin in women with type 2 diabetes in pregnancy (MiTy): a multicentre, international, randomised, placebo-controlled trial. Lancet Diabetes Endocrinol 8(10):834–844

    Article  CAS  PubMed  Google Scholar 

  • Fernandez H, Morin-Surruca M, Torre A, Faivre E, Deffieux X, Gervaise A (2011) Ovarian drilling for surgical treatment of polycystic ovarian syndrome: a comprehensive overview. Reprod BioMed Online 22:556

    Article  PubMed  Google Scholar 

  • Filicori M, Butler JP, Crowley WF Jr (1984) Neuroendocrine regulation of the corpus luteum in the human: evidence for pulsatile progesterone secretion. J Clin Invest 73:1638

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Franik S, Eltrop SM, Kremer JA, Kiesel L, Farquhar C (2018) Aromatase inhibitors (letrozole) for subfertile women with polycystic ovary syndrome. Cochrane Database Syst Rev 5(5):CD010287

    PubMed  Google Scholar 

  • Frank-Herrmann P, Gnoth C, Baur S, Strowitzki T (2006) Natürliche Familienplanung. Gynäkologe 39:671

    Article  Google Scholar 

  • Franks S (1995) Polycystic ovary syndrome. N Engl J Med 333:853

    Article  CAS  PubMed  Google Scholar 

  • Gelety TJ, Buyalos RP (1993) The effect of clomiphene citrate and menopausal gonadotropins on cervical mucus in ovulatory cycles. Fertil Steril 60:471

    Article  CAS  PubMed  Google Scholar 

  • Genazzani AD, Petraglia F, Battaglia C et al (1997) A long-term treatment with gonadotropin-releasing hormone agonist plus a low-dose oral contraceptive improves the recovery of the ovulatory function in patients with polycystic ovary syndrome. Fertil Steril 67:463

    Article  CAS  PubMed  Google Scholar 

  • Germond M, Desole S, Senn A et al (1992) Successful in vitro fertilisation and embryo transfer after treatment with recombinant human FSH. Lancet 339:1170

    Article  CAS  PubMed  Google Scholar 

  • Glueck CJ, Wang P, Fontaine R, Tracy T, Sieve-Smith L (1999) Metformin induced resumption of normal menses in 39 of 43 (91 %) previously amenorrheic women with the polycystic ovary syndrome. Metabolism 48:511

    Article  CAS  PubMed  Google Scholar 

  • Glueck CJ, Phillips H, Cameron D, Sieve-Smith L, Wang P (2001) Continuing metformin throughout pregnancy in women with polycystic ovary syndrome appears to safely reduce first-trimester spontaneous abortion: a pilot study. Fertil Steril 75:46

    Article  CAS  PubMed  Google Scholar 

  • Glueck CJ, Pranikoff J, Aregawi D, Wang P (2008) Prevention of gestational diabetes by metformin plus diet in patients with polycystic ovary syndrome. Fertil Steril 89:625

    Article  CAS  PubMed  Google Scholar 

  • Gnoth C, Frank-Herrmann P, Bremme M, Freundl G, Godehardt E (1996) Wie korrelieren selbstbeobachtete Zyklussymptome mit der Ovulation? Zentralbl Gynäkol 118:650

    CAS  PubMed  Google Scholar 

  • Gnoth C, Godehardt D, Godehardt E et al (2003) Time to pregnancy: results of a German prospective study and impact on the management of infertility. Hum Reprod 18:1959

    Article  CAS  PubMed  Google Scholar 

  • Gordon CM, Ackerman KE, Berga SL, Kaplan JR, Mastorakos G, Misra M, Murad MH, Santoro NF, Warren MP (2017) Functional hypothalamic amenorrhea: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 102(5):1413–1439

    Article  PubMed  Google Scholar 

  • Graf MA, Fischer R (1996) Diagnostik und Therapie beim ovariellen Hyperstimulationssyndrom. Gynäkologe 29:300

    Google Scholar 

  • Grimbizis GF, Di Spiezio SA, Saravelos SH, Gordts S, Exacoustos C, Van Schoubroeck D, Bermejo C, Amso NN, Nargund G, Timmerman D, Athanasiadis A, Brucker S, De Angelis C, Gergolet M, Li TC, Tanos V, Tarlatzis B, Farquharson R, Gianaroli L, Campo R (2016) The Thessaloniki ESHRE/ESGE consensus on diagnosis of female genital anomalies. Hum Reprod 31:2–7

    Article  PubMed  Google Scholar 

  • Hammond MG, Halme JK, Talbert LM (1983) Factors affecting the pregnancy rate in clomiphene citrate induction of ovulation. Obstet Gynecol 62(2):196–202

    CAS  PubMed  Google Scholar 

  • Homburg R, Hendriks ML, König TE et al (2012) Clomifene citrate or low-dose FSH for the first-line treatment of infertile women with anovulation associated with polycystic ovary syndrome: a prospective randomized multinational study. Hum Reprod 27:468

    Article  CAS  PubMed  Google Scholar 

  • Howles CM, Loumaye E, Germond M et al (1999) Does growth-hormone releasing factor assist follicular development in poor responder patients undergoing ovarian stimulation for in-vitro fertilization? Hum Reprod 14:1939

    Article  CAS  PubMed  Google Scholar 

  • Hughes E, Collins J, Vandekerckhove P (2000) Ovulation induction with urinary follicle stimulating hormone versus human menopausal gonadotropin for clomiphene-resistant polycystic ovary syndrome. Cochrane Database Syst Rev (2):CD000087

    Google Scholar 

  • Hughes E, Brown J, Collins JJ, Vanderkerchove P (2010) Clomiphene citrate for unexplained subfertility in women. Cochrane Database Syst Rev 2010:CD000057

    PubMed  PubMed Central  Google Scholar 

  • Jensen A, Sharif H, Kjaer SK (2009) Use of fertility drugs and risk of uterine cancer: results from a large Danish population-based cohort study. Am J Epidemiol 170:1408

    Article  PubMed  Google Scholar 

  • Jones GS (1976) The luteal phase defect. Fertil Steril 27:351

    Article  CAS  PubMed  Google Scholar 

  • Jordan J, Craig K, Clifton D, Soules M (1994) Luteal phase defect: the sensitivity and specificity of diagnostic methods in common clinical use. Fertil Steril 62:54

    Article  CAS  PubMed  Google Scholar 

  • Karamardian LM, Grimes DA (1992) Luteal phase deficiency: effect of treatment on pregnancy rates. Am J Obstet Gynecol 167:1391

    Article  CAS  PubMed  Google Scholar 

  • Kolibianakis EM, Zikopoulos KA, Fatemi HM, Osmanagaoglu K, Evenpoel J, Van Steirteghem A, Devroey P (2004) Endometrial thickness cannot predict ongoing pregnancy achievement in cycles stimulated with clomiphene citrate for intrauterine insemination. Reprod BioMed Online 8:115

    Article  CAS  PubMed  Google Scholar 

  • Kriplani A, Manchanda R, Agarwal N, Nayar B (2001) Laparoscopic ovarian drilling in clomiphene citrate-resistant women with polycystic ovary syndrome. J Am Assoc Gynecol Laparosc 8:511

    Article  CAS  PubMed  Google Scholar 

  • Kyrou D, Fatemi HM, Tournaye H, Devroey P (2010) Luteal phase support in normo-ovulatory women stimulated with clomiphene citrate for intrauterine insemination: need or habit? Hum Reprod 25:2501

    Article  CAS  PubMed  Google Scholar 

  • Lefebvre P, Bringer J, Renard E et al (1997) Influences of weight, body fat patterning and nutrition on the management of PCOS. Hum Reprod 12(Suppl. 1):72

    Article  PubMed  Google Scholar 

  • Legro RS, Finegood D, Dunaif A (1998) A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome. J Clin Endocrinol Metab 83:2694

    CAS  PubMed  Google Scholar 

  • Legro RS, Kunselman AR, Dodson WC, Dunaif A (1999) Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol Metab 84:165

    CAS  PubMed  Google Scholar 

  • Legro RS, Barnhart HX, Schlaff WD et al. Cooperative Multicenter Reproductive Medicine Network (2007) Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. New Engl J Med 356: 551

    Google Scholar 

  • Leyendecker G, Wildt L, Hansmann M (1980) Pregnancies following chronic intermittent (pulsatile) administration of Gn-RH by means of a portable pump (“Zyklomat”) – a new approach to the treatment of infertility in hypothalamic amenorrhea. J Clin Endocrinol Metab 51:1214

    Article  CAS  PubMed  Google Scholar 

  • Liguori G, Tolino A, Moccia G et al (1996) Laparoscopic ovarian treatment in infertile patients with polycystic ovarian syndrome (PCOS): endocrine changes and clinical outcome. Gynecol Endocrinol 10:257

    Article  CAS  PubMed  Google Scholar 

  • Ludwig M, Sonntag B (2010) LUF Syndrom – häufig, selten oder nicht existent? Gynäkologische Endokrinologie 8:112

    Article  Google Scholar 

  • Lunenfeld B, Sulimovici S, Rabau E, Eshkol A (1962) L’induction de l’ovulation dans les amenorrhees hypophysaires par un traitement combine de gonadotrophines urinaires menopausiques et de gonadotrophines chorioniques. Comptes rendus Soc Franc Gynecologie 5:1

    Google Scholar 

  • Lunenfeld B, Insler V, Glezerman M (1993) Diagnosis and treatment of functional infertility, 3. Aufl. Blackwell Wissenschaft, Berlin, S 98

    Google Scholar 

  • Mendenhall HW (1984) Evaluation and management of dysfunctional uterine bleeding. Semin Reprod Endocrinol 2:369

    Article  Google Scholar 

  • Moltz L, Trapp M, Bispink G, Leidenberger F (1987) Rationelle hormonale Diagnostik der sekundären Amenorrhoe. Geburtshilfe Frauenheilkd 47:228

    Article  CAS  PubMed  Google Scholar 

  • Moran LJ, Brinkworth G, Noakes M, Norman RJ (2006) Effects of lifestyle modification in polycystic ovarian syndrome. Reprod BioMed Online 12:569

    Article  PubMed  Google Scholar 

  • Moran LJ et al (2010) Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update 16(4):347–363

    Article  CAS  PubMed  Google Scholar 

  • Morin-Papunen L, Rantala AS, Unkila-Kallio L et al (2012) Metformin improves pregnancy and live-birth rates in women with polycystic ovary syndrome (PSOC): a multicenter, double-blind, placebo-controlled randomized trial. J Clin Endocrinol Metab 97:1492

    Article  CAS  PubMed  Google Scholar 

  • Morley LC, Tang T, Yasmin E, Norman RJ, Balen AH (2017) Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database Syst Rev 11(11):CD003053

    PubMed  Google Scholar 

  • Moro F, Scarinci E, Palla C, Romani F, Familiari A, Tropea A, Leoncini E, Lanzone A, Apa R (2015) Highly purified hMG versus recombinant FSH plus recombinant LH in intrauterine insemination cycles in women ≥35 years: a RCT. Hum Reprod 30(1):179–185

    Article  CAS  PubMed  Google Scholar 

  • Nahuis M, van der Veen F, Oosterhuis J, Mol BW, Hompes P, van Wely M (2010) Review of the safety, efficacy, costs and patient acceptability of recombinant follicle-stimulating hormone for injection in assisting ovulation induction in infertile women. Int J Womens Health 9:205

    Google Scholar 

  • Nasseri S, Ledger WL (2001) Clomiphene citrate in the twenty-first century. Hum Fertil (Camb) 4:145

    Article  CAS  PubMed  Google Scholar 

  • NICE clinical guidelines (2013) Fertility: assessment and treatment for people with fertility problems. Royal College of Obstetricians and Gynaecologists

    Google Scholar 

  • Nugent D, Vandekerckhove P, Hughes E et al (2000) Gonadotrophin therapy for ovulation induction in subfertility associated with polycystic ovary syndrome. Cochrane Database Syst Rev (4):CD000410

    Google Scholar 

  • Oates-Whitehead RM, Haas DM, Carrier JA (2003) Progestogen for preventing miscarriage. Cochrane Database Syst Rev 4:CD003511

    Google Scholar 

  • Palatnik A, Strawn E, Szabo A, Robb P (2012) What is the optimal follicular size before triggering ovulation in intrauterine insemination cycles with clomiphene citrate or letrozole? An analysis of 988 cycles. Fertil Steril 97:1089–1094

    Article  CAS  PubMed  Google Scholar 

  • Palomba S, Pasquali R, Orio F Jr, Nestler JE (2009a) Clomiphene citrate, metformin or both as first-step approach in treating anovulatory infertility in patients with polycystic ovary syndrome (PCOS): a systematic review of head-to-head randomized controlled studies and meta-analysis. Clin Endocrinol 70:311

    Article  CAS  Google Scholar 

  • Palomba S, Falbo A, Orio F Jr, Zullo F (2009b) Effect of preconceptional metformin on abortion risk in polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials. Fertil Steril 92:1646

    Article  CAS  PubMed  Google Scholar 

  • Pasquali R, Gambineri A, Biscotti D et al (2000) Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome. J Clin Endocrinol Metab 85:2767

    Article  CAS  PubMed  Google Scholar 

  • Practice Committee (2015) Current clinical irrelevance of luteal phase deficiency: a committee opinion. Fertil Steril 103(4):e27–e32

    Article  Google Scholar 

  • Pritts EA (2010) Letrozole for ovulation induction and controlled ovarian hyperstimulation. Curr Opin Obstet Gynecol 22:289

    Article  PubMed  Google Scholar 

  • Pundir J, Charles D, Sabatini L, Hiam D, Jitpiriyaroj S, Teede H, Coomarasamy A, Moran L, Thangaratinam S (2019) Overview of systematic reviews of non-pharmacological interventions in women with polycystic ovary syndrome. Hum Reprod Update 25(2):243–256

    Article  CAS  PubMed  Google Scholar 

  • Qublan H, Amarin Z, Nawasreh M, Diab F, Malkawi S, Al-Ahmad N, Balawneh M (2006) Luteinized unruptured follicle syndrome: incidence and recurrence rate in infertile women with unexplained infertility undergoing intrauterine insemination. Hum Reprod 21:2110

    Article  CAS  PubMed  Google Scholar 

  • Ragni G, Caliari I, Nicolosi AE, Arnoldi M, Somigliana E, Crosignani PG (2006) Preventing high-order multiple pregnancies during controlled ovarian hyperstimulation and intrauterine insemination: 3 years’ experience using low-dose recombinant follicle-stimulating hormone and gonadotropin-releasing hormone antagonists. Fertil Steril 85:619

    Article  CAS  PubMed  Google Scholar 

  • Reefhuis J, Honein MA, Schieve LA, Rasmussen SA, the National Birth Defects Prevention Study (2011) Use of clomiphene citrate and birth defects, National Birth Defects Prevention Study, 1997–2005. Hum Reprod 26:451

    Article  CAS  PubMed  Google Scholar 

  • Reh A, Grifo J, Danoff A (2010) What is a normal thyroid-stimulating hormone (TSH) level? Effects of stricter TSH thresholds on pregnancy outcomes after in vitro fertilization. Fertil Steril 94:2920

    Article  CAS  PubMed  Google Scholar 

  • Rossing MA, Daling JR, Weiss NS et al (1994) Ovarian tumors in a cohort of infertile women. N Engl J Med 331:771

    Article  CAS  PubMed  Google Scholar 

  • Rossmanith WG, Laughlin GA, Mortola JF et al (1990) Pulsatile cosecretion of estradiol and progesterone by the midluteal phase corpus luteum: temporal link to luteinizing hormone pulses. J Clin Endocrinol Metab 70:990

    Article  CAS  PubMed  Google Scholar 

  • Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81:19

    Article  Google Scholar 

  • Schmidt PJ, Nieman LK, Danaceau MA, Adams LF, Rubinow DR (1998) Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome. N Engl J Med 338(4):209

    Article  CAS  PubMed  Google Scholar 

  • Schoenaker DAJM, Stephenson J, Connolly A, Shillaker S, Fishburn S, Barker M, Godfrey KM, Alwan NA, UK Preconception Partnership (2021) Characterising and monitoring preconception health in England: a review of national population-level indicators and core data sources. J Dev Orig Health Dis 4:1–14

    Google Scholar 

  • Seli E, Arici A (2021) Ovulation induction with clomiphene citrate. UpToDate Wolters Kluwer Health, Topic 7400 Version 25.0

    Google Scholar 

  • Sharpe A, Morley LC, Tang T, Norman RJ, Balen AH (2019) Metformin for ovulation induction (excluding gonadotrophins) in women with polycystic ovary syndrome. Cochrane Database Syst Rev 12(12):CD013505

    PubMed  Google Scholar 

  • Shoham Z, Borenstein R, Lunenfeld B, Pariente C (1990) Hormonal profiles following clomiphene citrate therapy in conception and nonconception cycles. Clin Endocrinol 33:271

    Article  CAS  Google Scholar 

  • Siebert TI, Viola MI, Steyn DW, Kruger TF (2012) Is metformin indicated as primary ovulation induction agent in women with PCOS? A systematic review and meta-analysis. Gynecol Obstet Investig 73:304

    Article  CAS  Google Scholar 

  • So S, Yamaguchi W, Murabayashi N, Miyano N, Tawara F (2019) Effect of moderately increased thyroid-stimulating hormone levels and presence of thyroid antibodies on pregnancy among infertile women. Reprod Med Biol 19:82–88

    Article  PubMed  PubMed Central  Google Scholar 

  • Steinberger E, Smith KD, Tcholakian RK et al (1979) Testosterone levels in female partners of infertile couples. Am J Obstet Gynecol 133:133

    Article  CAS  PubMed  Google Scholar 

  • Steiner AZ, Terplan M, Paulson RJ (2005) Comparison of tamoxifen and clomiphene citrate for ovulation induction: a meta-analysis. Hum Reprod 20:1511

    Article  CAS  PubMed  Google Scholar 

  • Streda R, Mardesic T, Sobotka V, Koryntova D, Hybnerova L, Jindra M (2012) Comparison of different starting gonadotropin doses (50, 75 and 100 IU daily) for ovulation induction combined with intrauterine insemination. Arch Gynecol Obstet 286:1055

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Tang T, Lord JM, Norman RJ, Yasmin E, Balen AH (2012) Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo-amenorrhea and subfertility. Cochrane Database Syst Rev 5:CD003053

    Google Scholar 

  • Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group (2008) Consensus on infertility treatment related to polycystic ovary syndrome. Hum Reprod 23:462

    Article  Google Scholar 

  • Toth B, Rösner S, Thöne C, Strowitzki T (2010) Lutealphaseninsuffizienz – Schwächelt der Gelbkörper wirklich? Gynäkologische Endokrinologie 8:105

    Article  Google Scholar 

  • Toth B, Baston-Büst DM, Behre HM, Bielfeld A, Bohlmann M, Bühling K, Dittrich R, Goeckenjan M, Hancke K, Kliesch S, Köhn FM, Krüssel J, Kuon R, Liebenthron J, Nawroth F, Nordhoff V, Pinggera GM, Rogenhofer N, Rudnik-Schöneborn S, Schuppe HC, Schüring A, Seifert-Klauss V, Strowitzki T, Tüttelmann F, Vomstein K, Wildt L, Wischmann T, Wunder D, Zschocke J (2019) Diagnosis and therapy before assisted reproductive treatments. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Register Number 015-085, February 2019) – Part 1, basic assessment of the woman. Geburtshilfe Frauenheilkd 79(12):1278–1292

    Article  PubMed  PubMed Central  Google Scholar 

  • Tranoulis A, Laios A, Pampanos A, Yannoukakos D, Loutradis D, Michala L (2018) Efficacy and safety of pulsatile gonadotropin-releasing hormone therapy among patients with idiopathic and functional hypothalamic amenorrhea: a systematic review of the literature and a meta-analysis. Fertil Steril 109(4):708–771

    Article  CAS  PubMed  Google Scholar 

  • Tulandi T, Martin J, Al-Fadhli R, Kabli N, Forman R, Hitkari J, Librach C, Greenblatt E, Casper RF (2006) Congenital malformations among 911 newborns conceived after infertility treatment with letrozole or clomiphene citrate. Fertil Steril 85:1761

    Article  CAS  PubMed  Google Scholar 

  • Van Wely M, Westergaard LG, Bossuyt PM, van der Veen F (2003) Effectiveness of human menopausal gonadotrophin versus recombinant follicle-stimulating hormone for controlled ovarian hyperstimulation in assisted reproductive cycles: a meta-analysis. Fertil Steril 80:1086

    Article  PubMed  Google Scholar 

  • Vaughn TC (1984) Dysfunctional uterine bleeding in the adolescent. Semin Reprod Biol 2:359

    Article  Google Scholar 

  • Veltman-Verhulst SM, Fauser BC, Eijkemans MJ (2012) High singleton live birth rate confirmed after ovulation induction in women with anovulatory polycystic ovary syndrome: validation of a prediction model for clinical practice. Fertil Steril 98:761

    Article  PubMed  Google Scholar 

  • Veltri F, Kleynen P, Grabczan L, Salajan A, Rozenberg S, Pepersack T, Poppe K (2018) Pregnancy outcomes are not altered by variation in thyroid function within the normal range in women free of thyroid disease. Eur J Endocrinol 178:189–197

    Article  CAS  PubMed  Google Scholar 

  • Viola MI, Meyer D, Kruger T (2011) Association between clomiphene citrate and visual disturbances with special emphasis on central retinal vein occlusion: a review. Gynecol Obstet Investig 71:73

    Article  CAS  Google Scholar 

  • Wallace KL, Johnson V, Sopelak V, Hines R (2011) Clomiphene citrate versus letrozole: molecular analysis of the endometrium in women with polycystic ovary syndrome. Fertil Steril 96:1051

    Article  CAS  PubMed  Google Scholar 

  • Wang AT, Mullan RJ, Lane MA, Hazem A, Prasad C, Gathaiya NW, Fernández-Balsells MM, Bagatto A, Coto-Yglesias F, Carey J, Elraiyah TA, Erwin PJ, Gandhi GY, Montori VM, Murad MH (2012) Treatment of hyperprolactinemia: a systematic review and meta-analysis. Syst Rev 24(1):33

    Article  CAS  Google Scholar 

  • Wang R, Li W, Bordewijk EM, Legro RS, Zhang H, Wu X, Gao J, Morin-Papunen L, Homburg R, König TE, Moll E, Kar S, Huang W, Johnson NP, Amer SA, Vegetti W, Palomba S, Falbo A, Özmen Ü, Nazik H, Williams CD, Federica G, Lord J, Sahin Y, Bhattacharya S, Norman RJ, van Wely M, Mol BW, Reproductive Medicine Network+; International Ovulation Induction IPDMA Collaboration (2019) First-line ovulation induction for polycystic ovary syndrome: an individual participant data meta-analysis. Hum Reprod Update 25(6):717–732

    Article  CAS  PubMed  Google Scholar 

  • Weil C (1986) The safety of bromocriptine in hyperprolactinaemic female infertility: a literature review. Curr Med Res Opin 10:172

    Article  CAS  PubMed  Google Scholar 

  • Weiss NS, Kostova E, Nahuis M, Mol BWJ, van der Veen F, van Wely M (2019) Gonadotrophins for ovulation induction in women with polycystic ovary syndrome. Cochrane Database Syst Rev 1(1):CD010290

    PubMed  Google Scholar 

  • Weller A, Daniel S, Koren G, Lunenfeld E, Levy A (2017) The fetal safety of clomiphene citrate: a population-based retrospective cohort study. BJOG 124(11):1664–1670

    Article  CAS  PubMed  Google Scholar 

  • Wesselink AK, Rothman KJ, Hatch EE, Mikkelsen EM, Sørensen HT, Wise LA (2017) Age and fecundability in a North American preconception cohort study. Am J Obstet Gynecol 217(6):667

    Article  PubMed Central  Google Scholar 

  • White DM, Polson DW, Kiddy D et al (1996) Induction of ovulation with low-dose gonadotropins in polycystic ovary syndrome: an analysis of 109 pregnancies in 225 women. J Clin Endocrinol Metab 81:3821

    CAS  PubMed  Google Scholar 

  • Wilcox AJ, Weinberg CR, Baird DD (1995) Timing of sexual intercourse in relation to ovulation. Effects on the probability of conception, survival of the pregnancy, and sex of the baby. N Engl J Med 333:1517

    Article  CAS  PubMed  Google Scholar 

  • Wiser A, Levron J, Kreizer D et al (2005) Outcome of pregnancies complicated by severe ovarian hyperstimulation syndrome (OHSS): a follow-up beyond the second trimester. Hum Reprod 20:910

    Article  CAS  PubMed  Google Scholar 

  • Wouts MH, Duisterhout JS, Kuik DJ, Schoemaker J (1987) The chance of spontaneous conception for the infertile couple referred to an academic clinic for reproductive endocrinology and fertility in the Netherlands. Eur J Obstet Gynecol Reprod Biol 26:243

    Article  CAS  PubMed  Google Scholar 

  • Wu CH, Winkel CA (1980) The effect of therapy initiation day on clomiphene citrate therapy. Fertil Steril 52:564

    Article  Google Scholar 

  • Zahradnik HP (2004) Prämenstruelles Syndrom – Ein gynäkologisch-endokrinologisches Problem. Gynäkologische Endokrinologie 2:64

    Google Scholar 

  • Zinaman MJ, Clegg ED, Brown CC, O’Connor J, Selevan SG (1996) Estimates of human fertility and pregnancy loss. Fertil Steril 65:503

    Article  CAS  PubMed  Google Scholar 

InternetLinks

Download references

Author information

Authors and Affiliations

  1. Abt. Gynäkologische Endokrinologie und Fertilitätsstörungen, Universitäts-Frauenklinik Heidelberg, Heidelberg, Deutschland

    T. Strowitzki

Authors
  1. T. Strowitzki
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to T. Strowitzki .

Editor information

Editors and Affiliations

  1. Abt. Gynäkologische Endokrinologie und Fertilitätsstörungen, Universitäts-Frauenklinik Heidelberg, Heidelberg, Deutschland

    Thomas Strowitzki

  2. Universitätsfrauenklinik Regensburg, Regensburg, Deutschland

    Olaf Ortmann

Rights and permissions

Reprints and permissions

Copyright information

© 2024 Der/die Autor(en), exklusiv lizenziert an Springer-Verlag GmbH, DE, ein Teil von Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Strowitzki, T. (2024). Diagnostik Therapie bei gestörter Ovarfunktion. In: Strowitzki, T., Ortmann, O. (eds) Klinische Endokrinologie für Frauenärzte. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-65517-7_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-65517-7_6

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-65516-0

  • Online ISBN: 978-3-662-65517-7

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation